NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.12
+0.11 (0.55%)
Nov 21, 2024, 4:00 PM EST - Market closed
NAMS Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$33.80
Upside
+67.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +78.93% | Nov 21, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +78.93% | Nov 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +78.93% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $37 | Buy | Reiterates | $37 | +83.90% | Sep 23, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +54.08% | Sep 5, 2024 |
| Needham | Needham | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +78.93% | Aug 28, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +54.08% | Jul 30, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $31 | Buy | Reiterates | $31 | +54.08% | Jun 7, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | May 15, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $35 | Buy | Initiates | $35 | +73.96% | Mar 14, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $35 | Buy | Initiates | $35 | +73.96% | Mar 13, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $31 | Buy | Maintains | $25 → $31 | +54.08% | Feb 29, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +49.11% | Jan 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $37 | Buy | Initiates | $37 | +83.90% | Jan 16, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $25 | Buy | Initiates | $25 | +24.25% | Oct 30, 2023 |
| Credit Suisse | Credit Suisse | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +9.34% | Apr 3, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.